These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38960425)
1. Measles in the vaccinated host. Stout R; Muir D; Sriskandan S BMJ Case Rep; 2024 Jul; 17(7):. PubMed ID: 38960425 [TBL] [Abstract][Full Text] [Related]
2. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children. Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235 [TBL] [Abstract][Full Text] [Related]
3. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. Vardas E; Kreis S J Clin Virol; 1999 Aug; 13(3):173-9. PubMed ID: 10443793 [TBL] [Abstract][Full Text] [Related]
4. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673 [TBL] [Abstract][Full Text] [Related]
5. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study]. He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468 [No Abstract] [Full Text] [Related]
6. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus. Molyneaux PJ; Mok JY; Burns SM; Yap PL J Infect; 1993 Nov; 27(3):251-3. PubMed ID: 8308316 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. Erdman DD; Heath JL; Watson JC; Markowitz LE; Bellini WJ J Med Virol; 1993 Sep; 41(1):44-8. PubMed ID: 8228936 [TBL] [Abstract][Full Text] [Related]
8. [Measles at the point of being eliminated]. De Ory F; Peña-Rey I Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):73-4. PubMed ID: 20096973 [No Abstract] [Full Text] [Related]
9. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes. Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775 [TBL] [Abstract][Full Text] [Related]
10. Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination. Helfand RF; Gary HE; Atkinson WL; Nordin JD; Keyserling HL; Bellini WJ Clin Diagn Lab Immunol; 1998 Mar; 5(2):135-8. PubMed ID: 9521134 [TBL] [Abstract][Full Text] [Related]
11. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100 [TBL] [Abstract][Full Text] [Related]
12. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children. Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870 [TBL] [Abstract][Full Text] [Related]
13. Measles, mumps, and rubella antibodies in vaccinated Baltimore children. King JC; Lichenstein R; Feigelman S; Luna C; Permutt TJ; Patel J Am J Dis Child; 1993 May; 147(5):558-60. PubMed ID: 8488803 [TBL] [Abstract][Full Text] [Related]
14. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
15. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. Frenkel LM; Nielsen K; Garakian A; Cherry JD Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011 [TBL] [Abstract][Full Text] [Related]
16. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of São Paulo, Brazil, 2000-2004. Ciccone FH; Carvalhanas TR; Afonso AM; Flannery B; Waldman EA Rev Soc Bras Med Trop; 2010; 43(3):234-9. PubMed ID: 20563487 [TBL] [Abstract][Full Text] [Related]
17. Phylogenetic and epidemiological analysis of measles outbreaks in Denmark, 2013 to 2014. Rasmussen LD; Fonager J; Knudsen LK; Andersen PH; Rønn J; Poulsen MW; Franck KT; Fischer TK Euro Surveill; 2015; 20(39):. PubMed ID: 26537105 [TBL] [Abstract][Full Text] [Related]
18. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Tischer A; Gerike E Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536 [TBL] [Abstract][Full Text] [Related]
19. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH; Saracen CL; Peter G Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [TBL] [Abstract][Full Text] [Related]
20. Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants. Malshe N; Palkar S; Kulkarni R; Lalwani S; Mishra AC; Arankalle V Vaccine; 2019 Mar; 37(11):1443-1448. PubMed ID: 30765170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]